Table 2.
Sample characteristics for TiOS-SF validation
Age (N = 92) | M | Range |
61 | 22–76 | |
N | Percent | |
Gender (n = 92) | ||
Male | 45 | 49 |
Female | 47 | 51 |
Educational level (n = 92) | ||
None/primary school | 2 | 2 |
Secondary/lower level vocational school | 53 | 58 |
College/university | 34 | 37 |
Other | 3 | 3 |
Country of origin (n = 92) | ||
Netherlands | 85 | 92 |
Other | 7 | 8 |
Time since diagnosis (n = 89) | ||
<1 year | 2 | 2 |
1–2 years | 22 | 25 |
3–4 years | 29 | 33 |
5–6 years | 18 | 20 |
>6 years | 18 | 20 |
Type of cancer (n = 92a) | ||
Colon | 29 | 32 |
Breast | 17 | 19 |
Lung | 15 | 16 |
Genitourinary | 18 | 20 |
Lymph nodes/bone marrow/blood | 10 | 11 |
Other | 10 | 11 |
Number of consultations with present oncologist (n = 92) | ||
1–10 consultations | 27 | 29 |
11–20 consultations | 29 | 32 |
21–30 consultations | 20 | 22 |
31–40 consultations | 5 | 5 |
>40 consultations | 9 | 10 |
Do not know | 2 | 2 |
aMultiple responses allowed, so percentages do not add up to 100%